News Focus
News Focus
Replies to #71977 on Biotech Values
icon url

DewDiligence

01/22/09 7:41 PM

#71978 RE: ThomasS #71977

RPRX – I concur with your insinuations and I surmise that the company is engaging in a Reg FD violation because it decided to take the calculated gamble that it would do more good than harm. Good in this context means inducing retail investors to buy or hold; harm means the outside chance of getting prosecuted by the SEC.

By simple arithmetic, one can see that the numbers reported by hptaxis via Miller’s newsletter do not tell the full story about how many of the patients randomized to Proellex completed a full course of therapy per protocol.